Ethanolamine salt of N- (3-methoxy-5-methylpyrazin-2yl)-2-(4-[1 ,3,4-oxadiazole-2-yl] phenyl) pyridine3-sulphonamide

Details for Australian Patent Application No. 2006271420 (hide)

International Classifications

Event Publications

7 February 2008 PCT application entered the National Phase

PCT publication WO2007/010235 Priority application(s): WO2007/010235

8 May 2008 Amendment Made

The nature of the amendment is: Amend the invention title to read Ethanolamine salt of N- (3-methoxy-5-methylpyrazin-2yl)-2-(4- [1 ,3,4-0xadiaz0le-2-yl] phenyl) pyridine-3-sulphonamide And to amend the co-inventor to read Good, Catherine; Montgomery, Frank; Hogan, Phillip

23 September 2010 Application Accepted

Published as AU-B-2006271420

18 November 2010 Amendment Made

The nature of the amendment is: Amend the invention title to read Ethanolamine salt of N- (3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazole-2-yl] phenyl) pyridine-3-sulphonamide

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.